冠状病毒nsp14外基核酶与nsp10辅因子的接口对于有效的病毒复制和酶活性至关重要
bioRxiv : the preprint server for biology
|October 10, 2024
概括
冠状病毒nsp14和nsp10之间的相互作用对于病毒复制和RNA合成至关重要. 针对这种nsp14-nsp10接口可能为抑制冠状病毒复制提供新的策略.
科学领域:
- 病毒学 病毒学
- 分子生物学分子生物学
- 生物化学 生化学
背景情况:
- 冠状病毒 (CoV) 使用复制-转录复合体 (RTC) 进行RNA合成,涉及各种非结构蛋白 (nsps).
- nsp14蛋白具有3'-5'外核酶 (ExoN) 活性,对于高保真性病毒RNA复制和病原体产生至关重要.
- 虽然nsp14的EXON活性被nsp10辅因子增强,但具体的相互作用决定因素及其在病毒复制中的重要性仍然不清楚.
研究的目的:
- 调查nsp14-nsp10相互作用接口对冠状病毒复制和酶活性的重要性.
- 为了确定nsp14-nsp10接口的特定残留物,对于它们的功能关联至关重要.
- 探索针对这种接口进行抗病毒策略的潜力.
主要方法:
- 在小鼠肝炎病毒 (MHV) 的nsp14-nsp10接口引入了氨酸替代突变.
- 分析了突变病毒的复制效率和体外外核酶活性.
- 在传染病毒中确定了第二位点突变,以了解适应机制.
主要成果:
- 在nsp14-nsp10接口上的氨酸替代物显著降低了体外外核酶活性和病毒复制.
- 产生了具有中间损伤的突变 (nsp14 K7A,D8A),与催化失活突变不同.
- 这些突变的传递导致了第二位突变的选择,这些突变恢复了复制和酶活性,突出了补偿机制.
结论:
- 对于有效的冠状病毒酶功能和病毒复制来说,nsp14-nsp10相互作用是必不可少的.
- 界面上的特定残留物是关键的,它们的破坏可以通过适应性突变来补偿.
- 针对nsp14-nsp10接口为开发针对冠状病毒的新型抗病毒疗法提供了一个有希望的途径.
相关概念视频
Leaky Scanning
5.1K
During most eukaryotic translation processes, the small 40S ribosome subunit scans an mRNA from its 5' end until it encounters the first start AUG codon. The large 60S ribosomal subunit then joins the smaller one to initiate protein synthesis. The location of the translation initiation is largely determined by the nucleotides near the start codon as there may be multiple translation initiation sites present on the mRNA. Marilyn Kozak discovered that the sequence RCCAUGG (where R...
5.1K
Viruses with RNA Genomes
5
RNA viruses are categorized into positive-strand, negative-strand, or double-stranded groups based on their genomic structure and replication mechanisms. This classification dictates how they exploit host cellular machinery for protein synthesis and replication. Some RNA viruses also utilize reverse transcription as part of their life cycle, further diversifying their replication strategies.Positive-Strand RNA VirusesPositive-strand RNA viruses have genomes that function directly as messenger...
5
Viral Replication: Lytic Cycle
7
Bacteriophages, or phages, are viruses that specifically infect bacteria. Among them, T-even bacteriophages, such as T4, exhibit a well-characterized lytic replication cycle in Escherichia coli (E. coli). This process ensures the rapid proliferation of the virus while ultimately leading to the destruction of the bacterial host.Attachment and DNA InjectionThe infection process begins with the recognition and binding of the T4 phage to the E. coli cell surface. Tail fibers of the phage...
7
Restarting Stalled Replication Forks
5.8K
DNA replication is initiated at sites containing predefined DNA sequences known as origins of replication. DNA is unwound at these sites by the minichromosome maintenance (MCM) helicase and other factors such as Cdc45 and the associated GINS complex.The unwound single strands are protected by replication protein A (RPA) until DNA polymerase starts synthesizing DNA at the 5’ end of the strand in the same direction as the replication fork. To prevent the replication fork from falling apart,...
5.8K
Viral Mutations
32.2K
A mutation is a change in the sequence of bases of DNA or RNA in a genome. Some mutations occur during replication of the genome due to errors made by the polymerase enzymes that replicate DNA or RNA. Unlike DNA polymerase, RNA polymerase is prone to errors because it is not capable of “proofreading” its work. Viruses with RNA-based genomes, like HIV, therefore accrue mutations faster than viruses with DNA-based genomes. Because mutation and recombination provide the raw material...
32.2K
RNA Interference
26.0K
RNA interference (RNAi) is a process in which a small non-coding RNA molecule blocks the post-transcriptional expression of a gene by binding to its messenger RNA (mRNA) and preventing the protein from being translated.
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
26.0K


